88784-37-6

Basic information

• Product Name: (S)-3-(3-METHOXYPHENYL)PIPERIDINE
• Synonyms: Piperidine, 3-(3-methoxyphenyl)-, (3S)-
• CAS NO: 88784-37-6
• Molecular Formula: C₁₂H₁₇NO
• Molecular Weight: 191.27
• Mol File: 88784-37-6.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 304℃
• Flash Point: 122℃
• Appearance: /
• Density: 1.003
• Vapor Pressure: 0.001mmHg at 25°C
• Refractive Index: 1.515
• Storage Temp.: 2-8°C
• CAS DataBase Reference: (S)-3-(3-METHOXYPHENYL)PIPERIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-3-(3-METHOXYPHENYL)PIPERIDINE(88784-37-6)
• EPA Substance Registry System: (S)-3-(3-METHOXYPHENYL)PIPERIDINE(88784-37-6)

Safety Data

• Hazardous Substances Data: 88784-37-6(Hazardous Substances Data)

Usage

General Description

(S)-3-(3-Methoxyphenyl)piperidine is an organic chemical compound that belongs to the class of piperidine derivatives. It is composed of a piperidine ring with a methoxyphenyl group attached to the third position, and it exists in two enantiomeric forms. This chemical has potential pharmacological properties and may be employed in the development of drugs targeting the central nervous system. Additionally, it can serve as a building block in the synthesis of various organic molecules. The compound’s structure and properties make it a subject of interest for researchers in medicinal chemistry and chemical synthesis.

InChI:InChI=1/C12H17NO/c1-14-12-6-2-4-10(8-12)11-5-3-7-13-9-11/h2,4,6,8,11,13H,3,5,7,9H2,1H3/t11-/m1/s1

Upstream product

• 79601-21-1 3-(3-methoxyphenylpiperidine) 
• 19725-18-9 (+)-3-(3-methoxyphenyl)piperidine hydrochloride 
• 450416-70-3 (-)-(S)-tert-butyl 3-(3-methoxyphenyl)piperidine-1-carboxylate 
• 65292-99-1 2-(3-methoxyphenyl)acetaldehyde 
• 450416-60-1 1-[(E)-2-(3-Methoxy-phenyl)-vinyl]-pyrrolidine 
• 450416-61-2 methyl 4-(3-methoxyphenyl)-5-oxopentanoate 
• 450416-64-5 (3S,8S,8aS)-8-(3-methoxyphenyl)-5-oxo-3-phenyl-2,3,6,7,8,8a-hexahydro-5H-oxazolo[3,2-a]pyridine 
• 450416-68-9 (3S)-1-[(1S)-2-hydroxy-1-phenylethyl]-3-(3-methoxyphenyl)piperidine 
• 626-55-1 3-Bromopyridine 
• 4373-67-5 3-(3-methoxyphenyl)pyridine 
• 36282-40-3 (3-methoxyphenyl)magnesium bromide 
• 89874-44-2 N-benzyl-3(S)-(3-methoxyphenyl)piperidine 
• 1234836-16-8 3-(3-methoxyphenyl)-1-p-toluenesulfonylpiperidine 
• 1234835-96-1 5-(3-methoxyphenyl)-1-p-toluenesulfonyl-1,2,3,6-tetrahydropyridine 

Downstream Products

• 89874-51-1 (+)-(S)-3-(3-methoxyphenyl)-1-propylpiperidine 
• 147161-52-2 (S)-N-cyanomethyl-3-(3-methoxyphenyl)piperidine 
• 147161-65-7 (S)-N-propyl-3-(3-methoxy-4-aminophenyl)piperidine 
• 147161-63-5 (S)-N-propyl-3-(3-methoxy-4-nitrophenyl)piperidine 
• 89874-67-9 S-3-(3-Methoxyphenyl-N-ethyl)piperidine 
• 1602922-49-5 (4-chlorophenyl)-carbamic acid (S)-2,2,2-trifluoro-1-[(S)-3-(3-methoxyphenyl)-piperidin-1-ylmethyl]-ethyl ester hydrochloride 
• 85966-89-8 preclamol 
• 1071930-35-2 trifluoromethanesulfonic acid 3-((S)-1-propyl-1-oxo-piperidin-3-yl)-phenyl ester 
• 146798-88-1 S-(-)-3-<(3-(((trifluoromethyl)sulfonyl)oxy)phenyl)-N-n-propyl>piperidine 

Relevant articles and documents

TRIAZACYCLODODECANSULFONAMIDE ("TCD")-BASED PROTEIN SECRETION INHIBITORS

Provided herein are triazacyclododecansulfonamide ("TCD")-based protein secretion inhibitors, such as inhibitors of Sec61, methods for their preparation, related pharmaceutical compositions, and methods for using the same. For example, provided herein are compounds of Formula (I) and pharmaceutically acceptable salts and compositions including the same. The compounds disclosed herein may be used, for example, in the treatment of diseases including inflammation and/or cancer.

Enantioselective synthesis of 2-substituted and 3-substituted piperidines through a bromoaminocyclization process

A catalytic enantioselective bromocyclization of olefinic amides using amino-thiocarbamates as the catalysts has been developed. The resulting enantioenriched 2-substituted 3-bromopiperidines can readily be transformed to 3-substituted piperidines through

N-OXIDE AND/OR DI-N-OXIDE DERIVATIVES OF DOPAMINE RECEPTOR STABILIZERS/MODULATORS DISPLAYING IMPROVED CARDIOVASCULAR SIDE-EFFECTS PROFILES

The invention relates to N-oxide and/or di-N-oxide derivatives of dopamine receptor stabilizers/modulators having the general formula (1) or (2) and pharmaceutical preparations containing the said compounds. Further, the invention relates the use of the s